http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111991525-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-51 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-8994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-756 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8994 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
filingDate | 2020-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-111991525-B |
titleOfInvention | Effective component group of Simiao pills and preparation method and application thereof |
abstract | The invention discloses an active ingredient group of Simiao pills, a preparation method thereof and application of the active ingredient group in preventing and treating diabetes, wherein the active ingredient group mainly comprises a component 1 and a component 2, the component 1 is a polysaccharide substance with the molecular weight of 300-10KDa, and the component 2 is a alkaloid component; according to weight percentage, the polysaccharide substance with the molecular weight of 300-10KDa accounts for 40-70%, and the alkaloid is more than 15%; the effective component group is obtained by adopting membrane separation and macroporous resin, and the effective component group can be applied to the preparation of the medicines for preventing and/or treating diabetes related diseases. The product prepared by the invention consists of a component 1 and a component 2, the two components have obvious synergistic effect, can play a role of reducing blood sugar by multiple components and multiple targets, and has wide application value. |
priorityDate | 2020-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 167.